Madden Securities Corp Prothena Corp Public LTD CO Transaction History
Madden Securities Corp
- $237 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
198Shares Held
44.5MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$159 Million7.5% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$70.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$53 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$50.7 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$30.7 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $645M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...